Concepedia

Abraham Gomez

AG

4

Publications

272

Citations

4

H-Index

2011

Active since

Affiliations

Edimer Pharmaceuticals (United States)(Current)

Abraham Gomez is an author at Edimer Pharmaceuticals (United States) specializing in medicine, health sciences, and clinical microbiology.

Top concepts

HealthMedicineAntibioticsMicrobiologyDrug ResistanceClinical MicrobiologyAntimicrobial ResistanceBacteriologyPharmacologyAntibacterial Mechanisms

Publications per year

2011–2014

4

Publications

4

Fidaxomicin Inhibits Spore Production in Clostridium difficile

Farah Babakhani, Laurent Bouillaut, Abraham Gomez et al. · Clinical Infectious Diseases · 2012 · 123 citations · Full text

Antibacterial Agents, Bacteriology, Antimicrobial Chemotherapy +21

Killing kinetics of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile

Farah Babakhani, Abraham Gomez, Nikki Robert et al. · Journal of Medical Microbiology · 2011 · 68 citations · Full text

Bacteriology, Antimicrobial Chemotherapy, Laboratory-derived Mutant Strains +19

Postantibiotic Effect of Fidaxomicin and Its Major Metabolite, OP-1118, against Clostridium difficile

Farah Babakhani, Abraham Gomez, Nikki Robert et al. · Antimicrobial Agents and Chemotherapy · 2011 · 60 citations · Full text

Major Metabolite, Standard Comparator, Antimicrobial Susceptibility +15

Skin Disorders in Overweight and Obese Patients and Their Relationship With Insulin

Abraham Gomez, María Elisa Vega Memije, Margarita Torres‐Tamayo et al. · Actas Dermo-Sifiliográficas · 2014 · 21 citations · Full text

Metabolic Disorder, Skin Disorders, Anthropometric Indicator +16

Rows per page

1–4 of 4